162 related articles for article (PubMed ID: 12149649)
1. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis.
Channavajhala P; Seldin DC
Oncogene; 2002 Aug; 21(34):5280-8. PubMed ID: 12149649
[TBL] [Abstract][Full Text] [Related]
2. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
[TBL] [Abstract][Full Text] [Related]
3. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
Lebrin F; Chambaz EM; Bianchini L
Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.
Llorens F; Roher N; Miró FA; Sarno S; Ruiz FX; Meggio F; Plana M; Pinna LA; Itarte E
Biochem J; 2003 Nov; 375(Pt 3):623-31. PubMed ID: 12901717
[TBL] [Abstract][Full Text] [Related]
6. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
[TBL] [Abstract][Full Text] [Related]
7. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CK2 activity provokes different responses in hormone-sensitive and hormone-refractory prostate cancer cells.
Hessenauer A; Montenarh M; Götz C
Int J Oncol; 2003 Jun; 22(6):1263-70. PubMed ID: 12738992
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome.
Berse M; Bounpheng M; Huang X; Christy B; Pollmann C; Dubiel W
J Mol Biol; 2004 Oct; 343(2):361-70. PubMed ID: 15451666
[TBL] [Abstract][Full Text] [Related]
11. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
[TBL] [Abstract][Full Text] [Related]
12. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1.
Chi LM; Yu JS; Chang YS
Biochem Biophys Res Commun; 2002 Jun; 294(3):586-91. PubMed ID: 12056807
[TBL] [Abstract][Full Text] [Related]
13. Dual effect of lysine-rich polypeptides on the activity of protein kinase CK2.
Romero-Oliva F; Jacob G; Allende JE
J Cell Biochem; 2003 May; 89(2):348-55. PubMed ID: 12704797
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase CK2 activates the atypical Rio1p kinase and promotes its cell-cycle phase-dependent degradation in yeast.
Angermayr M; Hochleitner E; Lottspeich F; Bandlow W
FEBS J; 2007 Sep; 274(17):4654-67. PubMed ID: 17725716
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.
Di Maira G; Brustolon F; Bertacchini J; Tosoni K; Marmiroli S; Pinna LA; Ruzzene M
Oncogene; 2007 Oct; 26(48):6915-26. PubMed ID: 17486073
[TBL] [Abstract][Full Text] [Related]
20. Differential targeting of protein kinase CK2 to the nuclear matrix upon transient overexpression of its subunits.
Yu S; Davis AT; Guo C; Green JE; Ahmed K
J Cell Biochem; 1999 Jul; 74(1):127-34. PubMed ID: 10381269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
